Johnson & Johnson Cash on Hand 2010-2024 | JNJ

Johnson & Johnson cash on hand for the quarter ending September 30, 2024 was $20.297B, a 13.67% decline year-over-year.

  • Johnson & Johnson cash on hand for 2023 was $22.927B, a 2.9% increase from 2022.
  • Johnson & Johnson cash on hand for 2022 was $22.281B, a 29.51% decline from 2021.
  • Johnson & Johnson cash on hand for 2021 was $31.608B, a 25.5% increase from 2020.

Johnson & Johnson Cash on Hand 2010-2024 | JNJ

  • Johnson & Johnson cash on hand for 2023 was $22.927B, a 2.9% increase from 2022.
  • Johnson & Johnson cash on hand for 2022 was $22.281B, a 29.51% decline from 2021.
  • Johnson & Johnson cash on hand for 2021 was $31.608B, a 25.5% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B